News

Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023

SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…

10 months ago

Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)

New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction in plasma…

10 months ago

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a…

10 months ago

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

                  Monthly information regarding the total number of voting rights and total number…

10 months ago

Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics

UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three…

10 months ago

AMN Healthcare to Hold Third Quarter 2023 Earnings Conference Call on Thursday, November 2, 2023

DALLAS, Oct. 05, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss…

10 months ago

Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA) (the “Company” or “Kineta”), a clinical-stage biotechnology company focused…

10 months ago

ABIONYX Pharma Completes a Capital Increase in Favor of Categories of Persons

Financial visibility extended to Q1 2025 without drawing on the equity-linked financing facilityTOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX…

10 months ago

Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials

VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / MindBio Therapeutics Corp. (CSE:MBIO);(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to…

10 months ago

Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction

VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / Verisante Technology, Inc. (TSXV:VER.H) (the "Company") previously announced on September 7,…

10 months ago